S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Hongfu Cai · Study
Home
/
Author
Hongfu Cai
1 works
· latest 2019
· 1 institutions
cluster: provisional
ORCID 0000-0002-4923-4882
Follow
Suggest an ORCID correction
h-index
1
i10
1
Citations
52
Works here
1
19
Most cited in this library
Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China
2019 · 52 citations
Works
1 shown
Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China
Clinical Therapeutics
·
2019
·
7 authors
52
citations